Interestingly, the stratified analysis found a very poor survival in association with high expression values of TSSC1 gene among patients with clinical characteristics similar to those of our patient, i.e., metastatic disease, age > 18 months, and MYCN amplified. This evidence concerns the gene MYCN and metastatic neoplasm.